SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-006803
Filing Date
2022-10-07
Accepted
2022-10-07 16:53:47
Documents
15
Period of Report
2022-10-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 38354
2 SEPARATION, CONSULTING AND RELEASE AGREEMENT pharmacyte_ex1001.htm EX-10.1 75620
3 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 12815
4 GRAPHIC image_001.jpg GRAPHIC 5553
  Complete submission text file 0001683168-22-006803.txt   333289

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pmcb-20221006.xsd EX-101.SCH 3097
6 XBRL LABEL FILE pmcb-20221006_lab.xml EX-101.LAB 34476
7 XBRL PRESENTATION FILE pmcb-20221006_pre.xml EX-101.PRE 22599
9 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3601
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 221301261
SIC: 2836 Biological Products, (No Diagnostic Substances)